Search bioRxiv⌕ Search

Biology subjects

Hembo, C. S.

Publications and source records attributed to Hembo, C. S..

2 recordsLinked to original sources

Chemically informed representations of amino acids enable learning beyond the canonical protein alphabet

Computational models of proteins typically represent sequences using a fixed twenty-letter alphabet describing canonical amino acids. Although this symbolic representation underlies most machine learning approaches to protein analysis, it abstracts away the chemical structure of residues and cannot naturally encode post-translational modifications (PTMs). As a result, current models struggle to incorporate chemical variation beyond the canonical amino acid alphabet. Here we introduce a chemically informed representation of peptides based on two-dimensional depictions of amino acid structures. Peptides are encoded as mosaics of residue depictions and embedded using a convolutional autoencoder, allowing machine learning models to learn physicochemical features directly from molecular structure. Because these representations capture chemical properties rather than symbolic residue identities, they enable learning across structurally related residues and support generalization to modified amino acids not explicitly observed during training. Applied to Major Histocompatibility Complex class I binding prediction, these embeddings achieve competitive performance while enabling chemically interpretable attribution of the molecular features driving predictions.

bioinformatics↗

Generative Modelling of Oncogene-carrying Extrachromosomal Circular DNA Biogenesis and Dynamics in Cells

Extrachromosomal circular DNAs (ecDNA) are focal gene amplifications frequently associated with cancer development and often indicating a poor prognosis. To understand the early dynamics of oncogene-carrying ecDNAs, we previously developed CRISPR-C, a tool for precise ecDNA generation by deleting specific chromosomal regions. Here, we adapted CRISPR-C to recreate tumor ecDNAs. This method also allowed us to enhance ecDNA generation efficiency by directly delivering Cas9 protein and sgRNAs as a ribonucleoprotein complex. By using the modified CRISPR-C, we successfully generated ecDNAs carrying oncogenes (EGFR, CDK4, MDM2, MYC, MYCN, FGFR2, ABCB1, and DHFR) in various human cell types. Furthermore, we demonstrated that our method could generate chimeric ecDNAs composed of target sequences from distant intra or inter-chromosomal regions. Using these generative ecDNA cell models, we studied the oncogene ecDNA expression and stability. The MDM2 expression was increased after CRISPR-C, while CDK4 was decreased indicating genomic-context dependent effect. The copy number of CRISPR-C generated CDK4 was ecDNA increased in cells after a long period of treatment with the CDK4 inhibitor palbociclib. Unlike CDK4, the CRISPR-C generated ABCB1 ecDNA was unstable in cells under normal growth conditions, but is stably retained when the cells were treated with colcemid, a recognized substrate for ABCB1. We thus provide valuable tools and an attractive platform for studying ecDNA biogenesisy and in vitro drug screening on ecDNA stability.

cancer biology↗